Alector (ALEC) announced that Neil Berkley, who has served as Alector’s CBO since March 2024, and CBO and Interim CFO since June 2025, has been appointed CFO, effective December 10, 2025. Berkley will continue to serve as CBO.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ALEC:
- Cautious Outlook for Alector: Uncertainties in Clinical Validation and Financial Concerns Lead to Sell Rating
- Alector price target lowered to 75c from $1.50 at Morgan Stanley
- Alector’s Strategic and Financial Challenges Prompt Sell Rating Amid Clinical Setbacks
- Alector’s Strategic Shift to ABC Platform: Promising CNS Delivery and Neurodegenerative Disease Solutions
- Cautious Outlook on Alector Amid Strategic Shift and Uncertain Clinical Prospects
